News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Achillion Pharmaceuticals, Inc. Sets IPO At $14-$16/Share
September 22, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, Sept 22 (Reuters) - Achillion Pharmaceuticals Inc. on Friday set its planned initial public offering at 4.5 million shares at an estimated price of $14 to $16 each.
>>>
Discuss This Story
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Pain
AbbVie enters world of pain in up to $715M deal with China’s Haisco
April 13, 2026
·
1 min read
·
Annalee Armstrong
Radiopharmaceuticals
Regeneron enters radiopharma ring with up to $4.3B Telix alliance
April 13, 2026
·
2 min read
·
Tristan Manalac
IPO tracker
Seaport, Hemab set sail for Nasdaq
April 13, 2026
·
9 min read
·
Tristan Manalac
Deals
Roche sticks with C4T, adding up to $1B for molecular glue partnership
April 9, 2026
·
2 min read
·
Tristan Manalac
